Health care stocks were advancing Friday afternoon, with the NYSE Health Care Index rising 0.7% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%.
The iShares Biotechnology ETF (IBB) climbed 1.3%.
In corporate news, Cardinal Health (CAH) reported fiscal Q1 results that topped Wall Street expectations amid a double-digit profit increase in its pharmaceutical and specialty solutions segment, prompting the drug distributor to lift its full-year earnings outlook. Its shares popped past 6%.
Waters (WAT) shares jumped 17% after the company's Q3 adjusted earnings and sales exceeded analysts' estimates. The firm also raised its 2024 earnings guidance.
Theriva Biologics (TOVX) shares surged 27% after it said late Thursday that it has been named as one of five finalists for Merck's (MRK) Advance Biotech Grant.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。